← Back
Tirzepatide
A GLP-1 receptor agonist medication used for diabetes and weight management, being studied for potential neuroprotective effects.
Check price →
1
sources
Mentioned by
All mentions
"I have seen some unpublished data that suggest that very low like 2.5 milligrams of tirzepatide as an example is meaningfully reducing blood-based and CSF-based markers of neuroinflammation and protein aggregation."
From:
381‒Alzheimer’s disease in women: how hormonal transitions impact the brain, new therapies, & more
•
▶ 2:00:55
•
Jan 2026
Attribution: Peter mentions seeing unpublished data showing tirzepatide's potential benefits for brain biomarkers at low doses